202 related articles for article (PubMed ID: 18297280)
1. Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages.
Tsagozis P; Eriksson F; Pisa P
Cancer Immunol Immunother; 2008 Oct; 57(10):1451-9. PubMed ID: 18297280
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
[TBL] [Abstract][Full Text] [Related]
3. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.
Giraudo E; Inoue M; Hanahan D
J Clin Invest; 2004 Sep; 114(5):623-33. PubMed ID: 15343380
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro.
Mani J; Vallo S; Barth K; Makarević J; Juengel E; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):250-5. PubMed ID: 22450844
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion.
Rietkötter E; Menck K; Bleckmann A; Farhat K; Schaffrinski M; Schulz M; Hanisch UK; Binder C; Pukrop T
Oncotarget; 2013 Sep; 4(9):1449-60. PubMed ID: 24036536
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma.
Veltman JD; Lambers ME; van Nimwegen M; Hendriks RW; Hoogsteden HC; Hegmans JP; Aerts JG
Br J Cancer; 2010 Aug; 103(5):629-41. PubMed ID: 20664588
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer.
Gallo M; De Luca A; Lamura L; Normanno N
Ann Oncol; 2012 Mar; 23(3):597-604. PubMed ID: 21551002
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
Corey E; Brown LG; Quinn JE; Poot M; Roudier MP; Higano CS; Vessella RL
Clin Cancer Res; 2003 Jan; 9(1):295-306. PubMed ID: 12538482
[TBL] [Abstract][Full Text] [Related]
10. Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.
Borghese C; Casagrande N; Pivetta E; Colombatti A; Boccellino M; Amler E; Normanno N; Caraglia M; De Rosa G; Aldinucci D
Oncotarget; 2017 Jun; 8(26):42926-42938. PubMed ID: 28477013
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2
Fowler DW; Copier J; Dalgleish AG; Bodman-Smith MD
Cancer Immunol Immunother; 2017 Sep; 66(9):1205-1215. PubMed ID: 28501938
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.
Coscia M; Quaglino E; Iezzi M; Curcio C; Pantaleoni F; Riganti C; Holen I; Mönkkönen H; Boccadoro M; Forni G; Musiani P; Bosia A; Cavallo F; Massaia M
J Cell Mol Med; 2010 Dec; 14(12):2803-15. PubMed ID: 19818098
[TBL] [Abstract][Full Text] [Related]
13. The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid.
Hiroshima Y; Maawy A; Hassanein MK; Menen R; Momiyama M; Murakami T; Miwa S; Yamamoto M; Uehara F; Yano S; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
PLoS One; 2014; 9(8):e103382. PubMed ID: 25116261
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines.
Dirican A; Erten C; Atmaca H; Bozkurt E; Kucukzeybek Y; Varol U; Oktay Tarhan M; Karaca B; Uslu R
J BUON; 2014; 19(4):1055-61. PubMed ID: 25536616
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines.
Asbagh LA; Uzunoglu S; Cal C
Int Braz J Urol; 2008; 34(3):355-63; discussion 364. PubMed ID: 18601766
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells.
Inoue S; Arai N; Tomihara K; Takashina M; Hattori Y; Noguchi M
Eur J Pharmacol; 2015 Aug; 761():44-54. PubMed ID: 25934567
[TBL] [Abstract][Full Text] [Related]
17. Immune modulation of CD4
Liu H; Wang SH; Chen SC; Chen CY; Lo JL; Lin TM
BMC Immunol; 2016 Nov; 17(1):45. PubMed ID: 27887569
[TBL] [Abstract][Full Text] [Related]
18. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration.
Odri G; Kim PP; Lamoureux F; Charrier C; Battaglia S; Amiaud J; Heymann D; Gouin F; Redini F
BMC Cancer; 2014 Mar; 14():169. PubMed ID: 24612486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
